The impact of living donor hypertension on later function of kidney graft in kidney transplantation
In conclusion, while an adverse impact of LD HT on later kidney function and fibrosis was measured, this effect seemed negligible after accounting for other more relevant clinical characteristics.
Authors
- Belén Ponte (ORCID: https://orcid.org/0000-0003-4730-6050)
- Sophie de Seigneux (ORCID: https://orcid.org/0000-0002-4243-366X)
- Sophie Huegli
- Patricia Hirt‐Minkowski (ORCID: https://orcid.org/0000-0002-5949-1022)
- Fadi Haidar (ORCID: https://orcid.org/0000-0002-8133-1105)
- Solange Moll (ORCID: https://orcid.org/0000-0002-1809-9884)
- Théodore Pasquier
- David Antoine Jaques (ORCID: https://orcid.org/0000-0003-3841-3049)
- Noémie Grouzmann
Institutions
- University Hospital of Basel (CH)
- University Hospital of Geneva (CH)
- Hôpital du Valais (CH)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3389/fmed.2025.1686473
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hôpitaux Universitaires de Genève
- European Renal Association-European Dialysis and Transplant Association